Immune regulation by SLAM family receptors and SAP-related adaptors

Nature Reviews Immunology

Volumn 6, Issue 1, 2006, Pages 56-66

  Veillette, André ^a,b,c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD150 ANTIGEN; CD48 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN SH2; PROTEIN SH2D1B; PROTEIN SH2D1C; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CYTOKINE PRODUCTION; CYTOPLASM; CYTOTOXICITY; DENDRITIC CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INHIBITION KINETICS; INNATE IMMUNITY; LYMPHOPROLIFERATIVE DISEASE; MEASLES VIRUS; MUTATION; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; TH2 CELL; THROMBOCYTE; X CHROMOSOME LINKED DISORDER;

ANIMALS; ANTIGENS, CD; GLYCOPROTEINS; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIGENE FAMILY; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 33244455863     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1761     Document Type: Review

References (107)

1. Cambier, J. C. Antigen and Fc receptor signalling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J. Immunol. 155, 3281-3285 (1995).
2. Chan, A. C., Desai, D. M. & Weiss, A. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12, 555-592 (1994).
3. Latour, S. & Veillette, A. Proximal protein tyrosine kinases in immunoreceptor signalling. Curr. Opin. Immunol. 13, 299-306 (2001).
4. Lanier, L. L. NK Cell Recognition. Annu. Rev. Immunol. 23, 225-274 (2005).
5. Sharpe, A. H. & Freeman, G. J. The B7-CD28 superfamily. Nature Rev. Immunol. 2, 116-126 (2002).
6. Cocks, B. G. et al. A novel receptor involved in T-cell activation. Nature 376, 260-263 (1995).
7. Engel, P., Eck, M. J. &Terhorst, C. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nature Rev. Immunol. 3, 813-821 (2003).
8. Veillette, A. & Latour, S. The SLAM family of immune-cell receptors. Curr. Opin. Immunol. 15, 277-285 (2003).
9. Nichols, K. E., Ma, C. S., Cannons, J. L., Schwartzberg, P. L. & Tangye, S. G. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol. Rev. 203, 180-199 (2005).
10. Latour, S. & Veillette, A. The SAP family of adaptors in immune regulation. Semin. Immunol. 16, 409-419 (2004).
11. Sayos, J. et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395, 462-469 (1998). This paper was the first to report the association between SLAM and SAP; along with references 12 and 13, it also described the existence of mutations of the SAP gene in patients with XLP.
12. Nichols, K. E. et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl Acad. Sci. USA 95, 13765-13770 (1998).
13. Coffey, A. J. et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nature Genet. 20, 129-135 (1998).
14. Thompson, A. D. et al. EAT-2 is a novel SH2 domain containing protein that is upregulated by Ewing's sarcoma EWS/FLI1 fusion gene. Oncogene 13, 2649-2658 (1996).
15. Sayos, J. et al. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. Int. Immunol. 12, 1749-1757 (2000).
16. Nichols, K. E. et al. Regulation of NKT cell development by SAP, the protein defective in XLP. Nature Med. 11, 340-345 (2005). This paper, in addition to references 44 and 45, describes the lack of NKT cells in SAP-deficient humans and mice.
17. Mikhalap, S. V. et al. CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis. J. Immunol. 162, 5719-5727 (1999).
18. Munitz, A. et al. 2B4 (CD244) is expressed and functional on human eosinophils. J. Immunol. 174, 110-118 (2005).
19. Morra, M. et al. Defective B cell responses in the absence of SH2D1A. Proc. Natl Acad. Sci. USA 102, 4819-4823 (2005). This paper, along with reference 37, suggested the existence of an intrinsic B-cell defect in SAP-deficient mice.
20. Nanda, N. et al. Platelet aggregation induces platelet aggregate stability via SLAM family receptor signalling. Blood 106, 3028-3034 (2005).
21. Roncagalli, R. et al. Negative regulation of natural killer cell functions by EAT-2, a SAP-related adaptor. Nature Immunol. 6, 1002-1010 (2005). The paper reported analyses of NK-cell functions in mice lacking EAT2 or ERT. It also described the existence of ERT, the third member of the SAP family.
22. Morra, M. et al. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells. EMBO J. 20, 5840-5852 (2001).
23. Tangye, S. G., Nichols, K. E., Hare, N. J. & van de Weerdt, B. C. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation. J. Immunol. 171, 2485-2495 (2003).
24. Latour, S. & Veillette, A. Molecular and immunological basis of X-linked lymphoproliferative disease. Immunol. Rev. 192, 212-224 (2003).
25. Purtilo, D. T., Cassel, C. K., Yang, J. P. & Harper, R. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1, 935-940 (1975).
26. Seemayer, T. A. et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr. Res. 38, 471-478 (1995).
27. Wu, C. et al. SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nature Immunol. 2, 410-414 (2001). This paper, in addition to references 28-33 and 43, provides analyses of immune cell dysfunctions in mice lacking expression of SAP.
28. Czar, M. J. et al. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proc. Natl Acad. Sci. USA 98, 7449-7454 (2001).
29. Yin, L. et al. Mice deficient in the X-linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine γ-herpesvirus-68 and hypo-γ-globulinemia. J. Med. Virol. 71, 446-455 (2003).
30. H2 cytokine regulation. Immunity 21, 707-717 (2004). This paper, together with reference 32, reported on genetic evidence supporting the involvement of SRC-related kinase FYNT in SAP-mediated functions in vivo.
31. Crotty, S., Kersh, E. N., Cannons, J., Schwartzberg, P. L. & Ahmed, R. SAP is required for generating long-term humoral immunity. Nature 421, 282-287 (2003).
32. Cannons, J. L. et al. SAP regulates T(H)2 differentiation and PKC-9-mediated activation of NF-κB1. Immunity 21, 693-706 (2004).
33. Hron, J. D., Caplan, L., Gerth, A. J., Schwartzberg, P. L. & Peng, S. L. SH2D1A regulates T-dependent humoral autoimmunity. J. Exp. Med. 200, 261-266 (2004).
34. + T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection. Blood 103, 1625-1631 (2004).
35. +T cells. J. Clin. Invest. 115, 1049-1059 (2005).
36. Shlapatska, L. M. et al. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J. Immunol. 166, 5480-5487 (2001).
37. Al-Alem et al. Impaired Ig class switch in mice deficient for the X-linked lymphoproliferative disease gene sap. Blood 106, 2069-2075 (2005).
38. + T cells against EBV-infected cells. Blood 105, 4383-4389 (2005).
39. Chen, G. et al. Signalling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice. J. Immunol. 175, 2212-2218 (2005).
40. Tangye, S. G., Phillips, J. H., Lanier, L. L. & Nichols, K. E. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165, 2932-2936 (2000). This paper, combined with references 41 and 42, describes defects in 2B4-mediated functions in NK cells from SAP-deficient patients with XLP.
41. Benoit, L., Wang, X., Pabst, H. F., Dutz, J. & Tan, R. Defective NK cell activation in X-linked lymphoproliferative disease. J. Immunol. 165, 3549-3553 (2000).
42. Nakajima, H. et al. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur. J. Immunol. 30, 3309-3318 (2000).
43. Bloch-Queyrat, C. et al. Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn. J. Exp. Med. 202, 181-192 (2005).
44. Chung, B., Aoukaty, A., Dutz, J., Terhorst, C. & Tan, R. Signalling lymphocytic activation molecule-associated protein controls NKT cell functions. J. Immunol. 174, 3153-3157 (2005).
45. Pasquier, B. et al. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201, 695-701 (2005).
46. Brigl, M. & Brenner, M. B. CD1: Antigen presentation and T cell function. Annu. Rev. Immunol. 22, 817-890 (2004).
47. Lee, K. M. et al. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J. Exp. Med. 199, 1245-1254 (2004). This paper, in combination with references 72-74, describes analyses of NK-cell functions in 2B4-deficient mice.
48. Sivori, S. et al. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl Acad. Sci. USA 99, 4526-4531 (2002).
49. Brown, M. H. et al. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med. 188, 2083-2090 (1998).
50. Latchman, Y., McKay, P. F. & Reiser, H. Identification of the 2B4 molecule as a counter-receptor for CD48. J. Immunol. 161, 5809-5812 (1998).
51. Tatsuo, H., Ono, N., Tanaka, K. & Yanagi, Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406, 893-897 (2000).
52. Hsu, E. C., Iorio, C., Sarangi, F., Khine, A. A. & Richardson, C. D. CDw150 (SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. Virology 279, 9-21 (2001).
53. Sayos, J. et al. Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP. Blood 97, 3867-3874 (2001).
54. Latour, S. et al. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nature Immunol. 2, 681-690 (2001). This paper was the first to report the involvement of FYNT in SAP-mediated signal transduction.
55. Chen, R. et al. Molecular dissection of 2B4 signalling: implications for signal transduction by SLAM-related receptors. Mol. Cell. Biol. 24, 5144-5156 (2004).
56. Poy, F. et al. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. Mol. Cell 4, 555-561 (1999).
57. Li, S. C. et al. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A. Curr. Biol. 9, 1355-1362 (1999).
58. Li, C., Iosef, C., Jia, C. Y., Han, V. K. & Li, S. S. Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signalling through the signalling lymphocyte activation molecule (SLAM) family of immune receptors. J. Biol. Chem. 278, 3852-3859 (2003).
59. Parolini, S. et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192, 337-346 (2000).
60. Simarro, M. et al. SAP increases FynT kinase activity and is required for phosphorylation of SLAM and Ly9. Int. Immunol. 16, 727-736 (2004).
61. Latour, S. et al. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation. Nature Cell Biol. 5, 149-154 (2003). This paper, along with reference 62, elucidated the molecular basis of the interaction between SAP and FYNT.
62. Chan, B. et al. SAP couples Fyn to SLAM immune receptors. Nature Cell Biol. 5, 155-160 (2003).
63. H2 cells. J. Immunol. 163, 5860-5870 (1999).
64. Wang, N. et al. The cell surface receptor SLAM controls T cell and macrophage functions. J. Exp. Med. 199, 1255-1264 (2004). This paper, in addition to reference 30, analysed immune phenotypes in SLAM-deficient mice.
65. + dendritic cells and is upregulated by IL-1β. J. Immunol 167, 1989-1995 (2001).
66. Bleharski, J. R., Niazi, K. R., Sieling, P. A., Cheng, G. & Modlin, R. L. Signalling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines. J. Immunol. 167, 3174-3181 (2001).
67. Kiel, M. J. et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109-1121 (2005).
68. Mathew, P. A. et al. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J. Immunol. 151, 5328-5337 (1993).
69. Valiante, N. M. & Trinchieri, G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J. Exp. Med. 178, 1397-1406 (1993).
70. Garni-Wagner, B. A., Purohit, A., Mathew, P. A., Bennett, M. & Kumar, V. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J. Immunol. 151, 60-70 (1993).
71. Nakajima, H., Cella, M., Langen, H., Friedlein, A. & Colonna, M. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur. J. Immunol. 29, 1676-1683 (1999).
72. Vaidya, S. V. et al. Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells. J. Immunol. 174, 800-807 (2005).
73. McNerney, M. E., Guzior, D. & Kumar, V. 2B4 (CD244)- CD48 interactions provide a novel MHC class I-independent system for NK cell self-tolerance in mice. Blood 106, 1337-1340 (2005).
74. Lee, K. M. et al. Requirement of homotypic NK cell interactions through 2B4 (CD244)/CD48 in the generation of NK effector functions. Blood 19 May 2005 (doi:10.1182/blood-2005-01-0185).
75. Tangye, S. G. et al. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signalling protein SAP. J. Immunol. 162, 6981-6985 (1999).
76. Roda-Navarro, P. et al. Dynamic redistribution of the activating 2B4/SAP complex at the cytotoxic NK cell immune synapse. J. Immunol. 173, 3640-3646 (2004).
77. Eissmann, P. et al. Molecular basis for positive and negative signalling by the natural killer cell receptor 2B4 (CD244). Blood 105, 4722-4729 (2005).
78. Schatzle, J. D. et al. Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4. Proc. Natl Acad. Sci. USA 96, 3870-3875 (1999).
79. Kumar, V. & McNerney, M. E. A new self: MHC-class-I-independent Natural-killer-cell self-tolerance. Nature Rev. Immunol. 5, 363-374 (2005).
80. Fernandez, N. C. et al. A subset of natural killer cells achieve self-tolerance without expressing inhibitory receptors specific for self MHC molecules. Blood 105, 4416-4423 (2005).
81. Bottino, C. et al. NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194, 235-246 (2001).
82. Falco, M. et al. Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. Eur. J. Immunol. 34, 1663-1672 (2004).
83. Flaig, R. M., Stark, S. & Watzl, C. Cutting edge: NTB-A activates NK cells via homophilic interaction. J. Immunol. 172, 6524-6527 (2004).
84. Valdez, P. A. et al. NTB-A, a new activating receptor in T cells that regulates autoimmune disease. J. Biol. Chem. 279, 18662-18669 (2004).
85. Howie, D. et al. Cutting edge: the SLAM family receptor Ly108 controls T cell and neutrophil functions. J. Immunol. 174, 5931-5935 (2005).
86. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15, 297-322 (1997).
87. Bouchon, A., Cella, M., Grierson, H. L., Cohen, J. I. & Colonna, M. Cutting edge: activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J. Immunol. 167, 5517-5521 (2001).
88. Kumaresan, P., Lai, W., Chuang, S., Bennett, M. & Mathew, P. CS1, a novel member of the CD2 family, is homophilic and regulates NK cell function. Mol. Immunol. 39, 1-8 (2002).
89. Eberl, G., Lowin-Kropf, B. & MacDonald, H. R. Cutting edge: NKT cell development is selectively impaired in Fyn- deficient mice. J. Immunol. 163, 4091-4094 (1999).
90. Gadue, P., Morton, N. & Stein, P. L. The Src family tyrosine kinase Fyn regulates natural killer T cell development. J. Exp. Med. 190, 1189-1196 (1999).
91. Wandstrat, A. E. et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 21, 769-780 (2004). This paper describes polymorphisms in the Slam-gene locus in a lupus-susceptible mouse strain.
92. Punnonen, J. et al. Soluble and membrane-bound forms of signalling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J. Exp. Med. 185, 993-1004 (1997).
93. Howie, D. et al. The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon-γ production. Blood 100, 2899-2907 (2002).
94. Mavaddat, N. et al. Signalling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. J. Biol. Chem. 275, 28100-28109 (2000).
95. Erlenhoefer, C. et al. CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J. Virol. 75, 4499-4505 (2001).
96. + effector αβ T cells. J. Immunol. 167, 6165-6170 (2001).
97. + T cell proliferation by 2B4/CD48 interactions. J. Immunol. 167, 6706-6710 (2001).
98. Aoukaty, A. & Tan, R. Association of the X-linked lymphoproliferative disease gene product SAP/ SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase. J. Biol. Chem. 277, 13331-13337 (2002).
99. Watzl, C., Stebbins, C. C. & Long, E. O. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J. Immunol. 165, 3545-3548 (2000).
100. Klem, J., Verrett, P. C., Kumar, V. & Schatzle, J. D. 2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: properties required for 2B4 lytic function. J. Immunol. 169, 55-62 (2002).
101. de la Fuente, M. A. et al. Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9. Blood 97, 3513-3520 (2001).
102. Martin, M., Del Valle, J. M., Saborit, I. & Engel, P. Identification of Grb2 as a novel binding partner of the signalling lymphocytic activation molecule-associated protein binding receptor CD229. J. Immunol. 174, 5977-5986 (2005).
103. de la Fuente, M. A., Pizcueta, P., Nadal, M., Bosch, J. & Engel, P. CD84 leukocyte antigen is a new member of the Ig superfamily. Blood 90, 2398-2405 (1997).
104. Martin, M. et al. CD84 functions as a homophilic adhesion molecule and enhances IFN-γ secretion: adhesion is mediated by Ig-like domain 1. J. Immunol. 167, 3668-3676 (2001).
105. Tangye, S. G., van de Weerdt, B. C., Avery, D. T. & Hodgkin, P. D. CD84 is upregulated on a major population of human memory B cells and recruits the SH2 domain containing proteins SAP and EAT-2. Eur. J. Immunol. 32, 1640-1649 (2002).
106. Tovar, V. et al. Mouse novel Ly9: a new member of the expanding CD150 (SLAM) family of leukocyte cell-surface receptors. Immunogenetics 54, 394-402 (2002).
107. Boles, K. S., Stepp, S. E., Bennett, M., Kumar, V. & Mathew, P. A. 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes. Immunol. Rev. 181, 234-249 (2001).